|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q4 FY2013
As of Dec 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash and cash equivalents | ||||||||||||||
| Restricted cash | ||||||||||||||
| Short-term bank deposits | ||||||||||||||
| Marketable securities | ||||||||||||||
| Accounts receivable (net of allowance of $6,365 and $2,538 at December 31, 2025 and 2024, respectively) | ||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||
| Total Current Assets | ||||||||||||||
| Long-Term Assets | ||||||||||||||
| Property and equipment, net | ||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||
| Intangible assets, net | ||||||||||||||
| Goodwill | ||||||||||||||
| Deferred Income Tax Assets, Net | ||||||||||||||
| Other assets | ||||||||||||||
| Total Long-Term Assets | ||||||||||||||
| Total Assets | ||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts payable | ||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||
| Short-term operating lease liability | ||||||||||||||
| Deferred revenue | ||||||||||||||
| Short-term payment obligation related to acquisitions | ||||||||||||||
| Total Current Liabilities | ||||||||||||||
| Long-Term Liabilities | ||||||||||||||
| Long-term operating lease liability | ||||||||||||||
| Payment obligation related to acquisition | ||||||||||||||
| Deferred taxes | ||||||||||||||
| Other long-term liabilities | ||||||||||||||
| Total Long-Term Liabilities | ||||||||||||||
| Total Liabilities | ||||||||||||||
| Shareholders' equity | ||||||||||||||
| Ordinary shares of ILS 0.03 par value - Authorized: 80,000,000 shares at December 31, 2025 and 2024; Issued: 39,140,303 and 44,940,392 at December 31, 2025 and 2024, respectively; Outstanding: 39,024,964 and 44,825,053 shares at December 31, 2025 and 2024, respectively | ||||||||||||||
| Additional paid-in capital | ||||||||||||||
| Treasury shares at cost (115,339 shares at December 31, 2025 and 2024) | ||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||
| Retained earnings | ||||||||||||||
| Total Shareholders' Equity | ||||||||||||||
| Total Liabilities and Shareholders' Equity | ||||||||||||||
Loading...